A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Information processing deficits are commonly found in psychiatric illnesses, while at the biochemical level serotonin seems to play a role in nearly all psychiatric disorders. Processing negativity (PN), mismatch negativity (MMN) and P300 amplitude are electrophysiological measures of information processing. The present study was designed to replicate and further extent the results of our initial study on the effects of a low dose of escitalopram (10 mg) on MMN, PN and P300 amplitude. In a randomised, double-blind, cross-over experiment, 20 healthy male volunteers received either a single, orally administered dose of 15 mg escitalopram (a highly selective serotonin reuptake inhibitor (SSRI)) or placebo, after which their PN, MMN and P300 amplitude were assessed. Similar to our initial study with 10 mg escitalopram, 15 mg escitalopram significantly increased MMN, while it did not affect P300 amplitude. In contrast to our initial study, however, the currently higher dose of escitalopram did not increase PN. Results support the view that a broad range of increased serotonergic activity enhances MMN, while the relationship between serotonin and PN seems more complex. The current study does not support a serotonergic involvement in P300 amplitude.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Evoked-potential correlates of stimulus uncertainty
Sutton, S., Braren, M., Zubin, J., & John, E. R. (1965) · Science · doi:10.1126/science.150.3700.1187 · Cited by 3,061
Analysis of the elements of attention: A neuropsychological approach
Mirsky, A. F., Anthony, B. J., Duncan, C. C., Ahearn, M. B., & Kellam, S. G. (1991) · Neuropsychology Review · doi:10.1007/bf01109051 · Cited by 874
Computerized assessment in neuropsychiatry using CANTAB: discussion paper.
Sahakian, B. J., & Owen, A. M. (1992) · Europe PMC (PubMed Central) · Cited by 793
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Mismatch negativity in schizophrenia: a meta-analysis
Umbricht, D., & Krljes, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.002 · Cited by 742 · cited 2×
“Since MMN is best observed in absence of attention, it is believed to reflect an automatic orienting reflex based on memory and comparison processes (Naatanen, et al., 1989; Naatanen, 1995; Naatanen, et al., 2005; Umbricht and Krljes, 2005).”
BackgroundIlle, N., Berg, P., & Scherg, M. (2002) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200203000-00002 · Cited by 741
Javitt, D. C., Steinschneider, M., Schroeder, C. E., & Arezzo, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11962 · Cited by 662
Early selective-attention effects on the evoked potential: A critical review and reinterpretation
Näätänen, R., & Michie, P. T. (1979) · Biological Psychology · doi:10.1016/0301-0511(79)90053-x · Cited by 661 · cited 1×
“Similar to MMN, PN reaches its maximum amplitude in the frontal areas of the brain; it is believed to reflect the capacity of a person to focus his or her attention (Naatanen and Michie, 1979).”
BackgroundMemory‐based or afferent processes in mismatch negativity (MMN): A review of the evidence
Näätänen, R., Jacobsen, T., & Winkler, I. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00256.x · Cited by 627
Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583
Research works printed but not linked: 5
- Aboraya, A., 1998, W V Med J, 94, 326
- Gene Cos, N., 1999, Neuropsychiatry Neuropsychol Behav Neurol, 12, 17
- Iwanami, A., 1998, J Psychiatry Neurosci, 23, 45
- Metting van Rijn, AC, Proc of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Sahakian, BJ, 1992, R.Soc.Med, 85, 399
Cited by
Näätänen, R., Kujala, T., Escera, C., Baldeweg, T., Kreegipuu, K., Carlson, S., & Ponton, C. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.09.020 · Cited by 425
Chitty, K. M., Lagopoulos, J., Lee, R. S. C., Hickie, I. B., & Hermens, D. F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.007 · Cited by 139
Todd, J., Michie, P. T., Schall, U., Ward, P. B., & Catts, S. V. (2011) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2011.10.003 · Cited by 139
“…support of this suggestion, a study employing more selective modulation of acetylecholine produced no significant change in MMN (Pekkonen et al., 2005) whilst a recent augmentation of serotonin (5-HT) levels via escitalopram produced a significant increase in MMN amplitude (Wienberg et al., 2010).”
BackgroundResultKenemans, J. L., & Kähkönen, S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.157 · Cited by 104
“Consistent acute nil effects have also been reported for 15 mg escitolapram (Wienberg et al, 2010), as well as in older studies using methysergide (Meador et al, 1989), and fenfluramine (Pritchard et al, 1987).”
Skandali, N., Rowe, J. B., Voon, V., Deakin, J. B., Cardinal, R. N., Cormack, F., Passamonti, L., Bevan-Jones, W. R., Regenthal, R., Chamberlain, S. R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0229-z · Cited by 89
Metadata
- Authors
- Wienberg, M., Glenthoj, B., Jensen, K., & Oranje, B.
- Affiliations
- University of Copenhagen (DK)
- Center for Neuropsychiatric Schizophrenia Research (CNSR), Faculty of Health sciences, Copenhagen University, University Psychiatric Center Glostrup, Glostrup, Denmark
- Corresponding author
- Oranje, B.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2009-03-20
- Volume
- 24
- Issue
- 8
- Pages
- 1183-1192
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2142648296
- Cited by
- 68
- References
- 57
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 12 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Lundbeckfonden
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- escitalopram, mismatch negativity, processing negativity, P300 amplitude, selective serotonin reuptake inhibitors, serotonin, event-related potentials, information processing deficits, healthy volunteers
- MeSH terms
- Acoustic Stimulation, Adult, Anxiety Disorders, Blood Pressure, Double-Blind Method, Electroencephalography, Evoked Potentials, Humans, Male, Mental Processes, Schizophrenia, Time Factors, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies, Event-Related Potentials, P300, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. https://app.cochat.ai/papers/10.1177/0269881109102606
- The paper
- Wienberg, M., Glenthoj, B., Jensen, K., & Oranje, B. (2010). A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. Journal of Psychopharmacology. https://doi.org/10.1177/0269881109102606
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.